Xenon Pharmaceuticals Inc  

(Public, NASDAQ:XENE)   Watch this stock  
Find more results for TEVA BIOPHARMACEUTICALS, INC
12.52
-0.13 (-1.03%)
Nov 24 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 12.50 - 12.75
52 week 9.21 - 18.48
Open 12.75
Vol / Avg. 28,472.00/162,138.00
Mkt cap 177.25M
P/E 44.22
Div/yield     -
EPS 0.28
Shares 14.18M
Beta     -
Inst. own 0%

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin 25.27% 43.98%
Operating margin 23.40% 35.50%
EBITD margin - 38.08%
Return on average assets 9.87% 20.43%
Return on average equity - -
Employees 63 -
CDP Score - -

Address

200-3650 Gilmore Way
BURNABY, BC V5G 4W8
Canada
+1-604-4843300 (Phone)
+1-604-4843450 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Xenon Pharmaceuticals Inc. (Xenon) is a clinical-stage biopharmaceutical company discovering and developing a pipeline of differentiated therapeutics for orphan indications. It has an integrated platform, which includes in-house capabilities for human genetics, small molecule drug discovery, and preclinical and clinical development. Its pharmaceutical partners include Teva Pharmaceutical Industries, Ltd. (Teva) (through its subsidiary, Ivax International GmbH), Genentech, Inc. (Genentech), and Merck & Co., Inc. (Merck) (through its affiliate, Essex Chemie AG).

Officers and directors

Michael M. Tarnow Chairman of the Board
Age: 70
Bio & Compensation  - Reuters
Ian C. Mortimer MBA., CPA., CMA. Chief Financial Officer
Age: 38
Bio & Compensation  - Reuters
Gary J. Bridger Ph.D. Executive Vice President of Research and Development
Age: 51
Bio & Compensation  - Reuters
Robin Sherrington Ph.D. Senior Vice President of Business and Corporate Development
Age: 53
Bio & Compensation  - Reuters
Charles M. Cohen Ph.D. Vice President - Biology
Age: 66
Bio & Compensation  - Reuters
Y Paul Goldberg M.B., ChB., Ph.D. Vice President of Clinical Development
Age: 54
Bio & Compensation  - Reuters
Karen G Corraini J.D. General Counsel and Corporate Secretary
Age: 59
Bio & Compensation  - Reuters
Simon N Pimstone M.B., ChB., Ph.D. President, Chief Executive Officer, Director
Age: 47
Bio & Compensation  - Reuters
Mohammad Azab MBA,, M.B., ChB. Director
Age: 58
Bio & Compensation  - Reuters
Johnston L. Evans Director
Age: 66
Bio & Compensation  - Reuters